This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Carthamus tinctorius, commonly known as safflower, is a medicinal herb and oilseed crop used for its cardiovascular, neuroprotective, and anti-inflammatory properties [PMID:40843199, PMID:38799156].
Background
Safflower (Carthamus tinctorius L.) is a member of the Asteraceae (Compositae) family [PMID:24502326, PMID:37069212]. It is an annual herb and oilseed crop cultivated worldwide, particularly in moisture-limited environments, and is valued for its high-quality edible oils rich in unsaturated fatty acids [PMID:24502326, PMID:37069212].
Traditional uses
In traditional medicine, it has been used as a purgative, analgesic, antipyretic, and antidote to poisoning [PMID:23371463]. It is utilized for treating dysmenorrhea, amenorrhea, postpartum abdominal pain and mass, trauma, joint pain, and postpartum hemorrhage [PMID:29881530, PMID:23371463]. It is also used to promote blood circulation, dredge meridians, eliminate blood stasis, and relieve pain [PMID:40843199].
Active compounds
The plant contains complex chemical components, predominantly flavonoids (including chalcone compounds, quercetin, rutin, and kaempferol) [PMID:40843199, PMID:36076573]. Other active constituents include Hydroxysafflor yellow A (HSYA), carthamidin, isocarthamidin, safflor yellow A, safflamin C, luteolin, alkaloids, organic acids, pigments, polysaccharides, and sesquiterpenoids [PMID:40368986, PMID:23371463, PMID:36558507, PMID:34744747]. Essential oils contain caryophyllene, p-allyltoluene, 1-acetoxytetralin, and heneicosane [PMID:23371463].
Mechanism of action
Safflower flavonoids exhibit antioxidant, anti-inflammatory, and neuroprotective effects [PMID:40843199]. Hydroxysafflor yellow A (HSYA) counteracts oxidative stress and reduces inflammation to exert anti-fibrotic effects in the liver [PMID:41764836]. In cerebral ischemia/reperfusion injury, safflower may protect the brain via the arachidonic acid/p53-mediated apoptosis axis [PMID:39776584] and by regulating the PARP-1/TAX1BP1-mediated mitochondrial respiratory chain complex I to antagonize parthanatos [PMID:39701216]. Certain polyacetylene glycosides inhibit adipogenesis by activating AMPK and suppressing lipogenic genes [PMID:33477919].
Clinical evidence
Evidence BMetabolic Syndrome
Administration of 8g safflower oil daily for 12 weeks resulted in significant reductions in waist circumference, systolic blood pressure, and diastolic blood pressure [PMID:34487844]
Evidence CIschemic Stroke
Used in many Asian countries to treat cerebrovascular diseases; HSYA is a clinical investigational new drug for acute ischemic stroke [PMID:39776584, PMID:40368986]
Evidence CAlzheimer's Disease
Investigated as a natural neuroprotective source for anti-Alzheimer's drugs [PMID:36041691]
Evidence DHypertension and Dyslipidemia
Network pharmacology suggests multi-component synergy targeting the AGE-RAGE and TNF signaling pathways [PMID:41391263]
Safety & adverse effects
Safflower oleosomes have shown encouraging results in animal models, but human clinical research is required to determine their efficacy and safety in dermatology [PMID:38060028].
Evidence summary
Evidence ranges from high-level clinical trials for metabolic syndrome (Level B) to preclinical animal models and computational network pharmacology (Level D) for cardiovascular and neuroprotective effects. Much of the current pharmacological data is based on reviews and in vitro/in vivo studies.
PubMed sources
1.PMID: 38060028 (2023) — The potential cutaneous benefits of Carthamus tinctorius oleosomes. · Archives of dermatological research
2.PMID: 41391263 (2026) — Multi-component synergy of safflower (Carthamus tinctorius L.) against hypertension-dyslipidemia: Network pharmacology and molecular docking study. · Computational biology and chemistry
4.PMID: 37069212 (2023) — Phylogenomic investigation of safflower (Carthamus tinctorius) and related species using genotyping-by-sequencing (GBS). · Scientific reports
5.PMID: 36041691 (2022) — Carthamus tinctorius L.: A natural neuroprotective source for anti-Alzheimer's disease drugs.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 38445357 (2024) — Pharmacokinetic study of multicomponent in Hong-Hua-Xiao-Yao tablet. · Biomedical chromatography : BMC
7.PMID: 40843199 (2025) — Pharmacological actions and applications of safflower flavonoids. · Frontiers in nutrition
8.PMID: 36076573 (2022) — Comprehensive review of two groups of flavonoids in Carthamus tinctorius L. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
9.PMID: 29881530 (2018) — Medical uses of Carthamus tinctorius L. (Safflower): a comprehensive review from Traditional Medicine to Modern Medicine. · Electronic physician
10.PMID: 35198336 (2022) — The Use of Safflower (Carthamus tinctorius) in Treating Depression and Anxiety. · Cureus
11.PMID: 40368986 (2025) — Elucidation of the biosynthetic pathway of hydroxysafflor yellow A. · Nature communications
12.PMID: 36558507 (2022) — Sesquiterpenoids from the Florets of Carthamus tinctorius (Safflower) and Their Anti-Atherosclerotic Activity. · Nutrients
13.PMID: 34744747 (2021) — Extraction, Structures, Bioactivities and Structure-Function Analysis of the Polysaccharides From Safflower (Carthamus tinctorius L.). · Frontiers in pharmacology
14.PMID: 38338349 (2024) — Highly Promiscuous Flavonoid Di-O-glycosyltransferases from Carthamus tinctorius L. · Molecules (Basel, Switzerland)
15.PMID: 23371463 (2013) — Phytochemistry, pharmacology and medicinal properties of Carthamus tinctorius L. · Chinese journal of integrative medicine
16.PMID: 41764836 (2026) — Hydroxy Safflower Yellow A: A Natural Compound from Carthamus tinctorius L. with Potent Activity Against Liver Fibrosis and Cancer. · Phytomedicine : international journal of phytotherapy and phytopharmacology
17.PMID: 40781704 (2025) — Genome-wide identification and analysis of the cytochrome P450 family elucidate flavonoid biosynthesis in safflower. · BMC plant biology
18.PMID: 37239339 (2023) — Complete Mitogenome and Phylogenetic Analysis of the Carthamus tinctorius L. · Genes
19.PMID: 38799156 (2024) — Genetic diversity, clinical uses, and phytochemical and pharmacological properties of safflower (Carthamus tinctorius L.): an important medicinal plant. · Frontiers in pharmacology
20.PMID: 33477919 (2021) — Anti-Adipogenic Polyacetylene Glycosides from the Florets of Safflower (Carthamus tinctorius). · Biomedicines
21.PMID: 32748813 (2020) — Antioxidant and Anti-Inflammatory Activities of Safflower (Carthamus tinctorius L.) Honey Extract. · Foods (Basel, Switzerland)
22.PMID: 39776584 (2024) — Carthamus tinctorius L. protects cerebral ischemia/reperfusion injury via arachidonic acid/p53-mediated apoptosis axis. · Frontiers in pharmacology
23.PMID: 32560514 (2020) — A Metabolic Perspective and Opportunities in Pharmacologically Important Safflower. · Metabolites
24.PMID: 37937336 (2023) — Safflower (Carthamus tinctorius Linn.) Inhibits Cell Proliferation and Induces Apoptotic in Breast Cancer Cell Lines T47D. · Pakistan journal of biological sciences : PJBS
25.PMID: 36506801 (2023) — An image dataset of diverse safflower (Carthamus tinctorius L.) genotypes for salt response phenotyping. · Data in brief
26.PMID: 35270178 (2022) — Adaptability and Stability of Safflower Genotypes for Oil Production. · Plants (Basel, Switzerland)
27.PMID: 39701216 (2025) — Astragalus membranaceus-Carthamus tinctorius herb pair antagonizes parthanatos in cerebral ischemia/reperfusion injury via regulating PARP-1/TAX1BP1-mediated mitochondrial respiratory chain complex I. · Journal of ethnopharmacology
28.PMID: 34487844 (2022) — Safflower (Carthamus tinctorius L.) oil could improve abdominal obesity, blood pressure, and insulin resistance in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled clinical trial. · Journal of ethnopharmacology
29.PMID: 40918514 (2025) — Carthamus tinctorius L.: a comprehensive review of its ethnomedicine, phytochemistry, pharmacology, and clinical applications. · Frontiers in pharmacology